SB 747651A: inhibits mitogen- and stress-activated kinase 1; structure in first source [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 91826488 |
| MeSH ID | M0571002 |
| Synonym |
|---|
| 4-(1-ethyl-7-((piperidin-4-ylamino)methyl)-1h-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine tetrahydrochloride |
| sb 747651 tetrahydrochloride |
| 2108968-31-4 |
| sb 747651a |
| D94224 |
| sb747651a |
| AS-79647 |
| 4-[1-ethyl-7-[(piperidin-4-ylamino)methyl]imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;tetrahydrochloride |
| sb-747651a 4hcl |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ro 31-8220 | imidothiocarbamic ester; indoles; maleimides | EC 2.7.11.13 (protein kinase C) inhibitor | 2012 | 2012 | 12.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| serine | L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| h 89 | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | 2012 | 2012 | 12.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | ||
| lysophosphatidic acid | 1-acyl-sn-glycerol 3-phosphate | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | ||
| oxadiazoles | 2012 | 2021 | 8.0 | high | 0 | 0 | 0 | 0 | 4 | 1 | |||
| interleukin-8 | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arthritis, Rheumatoid | 0 | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| Astrocytoma, Grade IV | 0 | 2021 | 2021 | 3.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
| Glioblastoma | 0 | 2021 | 2021 | 3.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
| Peritonitis | 0 | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| Primary Peritonitis | 0 | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| Rheumatoid Arthritis | 0 | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |